drugset

drugset / Trial / NCT01291823

Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

NCT01291823 ↗

Phase 2 Unknown 70 enrolled Zhejiang Cancer Hospital

NaSingle-groupOpen-labelTreatment

Summary

Elderly patients with esophageal cancer will receive thoracic radiation therapy 54-60Gy over 30 fractions, and concurrent with Gefitinib.

Timeline

Start: 2010-12
Primary completion: 2012-12
Completion: 2014-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gefitinib	Small molecule	250 mg	—

Indications